CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-15 | Lenk Robert P Director | Purchase | +1,000 | $1.77 | $2K | 24,160 |
| 2023-11-13 | Lenk Robert P Director | Purchase | +4,000 | $1.43 | $6K | 23,160 |
| 2023-11-10 | Lenk Robert P Director | Purchase | +2,000 | $1.45 | $3K | 19,160 |
| 2023-11-09 | Lenk Robert P Director | Purchase | +4,199 | $1.59 | $7K | 17,160 |
| 2023-11-08 | Lenk Robert P Director | Purchase | +5,000 | $1.65 | $8K | 12,961 |
| 2023-11-07 | Lenk Robert P Director | Purchase | +6,000 | $1.64 | $10K | 7,961 |
| 2023-11-06 | Lenk Robert P Director | Purchase | +1,395 | $1.50 | $2K | 1,961 |
| 2023-09-13 | Clowes Howard Director | Purchase | +6,993 | $1.43 | $10K | 11,693 |
| 2023-09-11 | Petersen Greg Director | Purchase | +20,000 | $1.70 | $34K | 24,166 |
| 2023-06-06 | Clowes Howard Director | Purchase | +1,000 | $3.98 | $4K | 4,700 |
| 2023-05-03 | Clowes Howard Director | Purchase | +2,500 | $3.64 | $9K | 3,700 |
| 2023-03-03 | Hawkins Richard J Director | Purchase | +1 | $1,000.00 | $1K | 1 |
| 2023-02-15 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +20,182 | 20,182 | ||
| 2023-02-15 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +104,404 | 104,404 | ||
| 2023-02-15 | Petersen Greg Director | Grant or award · Stock Option (Right to Buy) | +20,182 | 20,182 | ||
| 2023-02-15 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +20,182 | 20,182 | ||
| 2023-02-15 | LaFrance Norman D. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +74,981 | 74,981 | ||
| 2023-02-15 | Clowes Howard Director | Grant or award · Stock Option (Right to Buy) | +20,182 | 20,182 | ||
| 2023-02-15 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +483,824 | 483,824 | ||
| 2022-12-30 | Lenk Robert P Director | Sale | −1,500 | $0.31 | $472 | 8,500 |
Page 8 of 53 · 1,048 trades